Valicenti Advisory Services Inc Laboratory Corp Of America Holdings Transaction History

Valicenti Advisory Services Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Jan 22, 2019	SELL	$120.82 - $174.09 $1.87 Million - $2.69 Million	-15,460 Closed	0 $0
Q3 2018 Oct 17, 2018	SELL	$167.67 - $188.27 $71,259 - $80,014	-425 Reduced 2.68%	15,460 $2.69 Million
Q2 2018 Jul 24, 2018	BUY	$160.33 - $189.41 $1.65 Million - $1.95 Million	10,270 Added 182.9%	15,885 $2.85 Million
Q1 2018 Apr 25, 2018	SELL	$161.53 - $178.11 $32,306 - $35,622	-200 Reduced 3.44%	5,615 $908,000
Q4 2017 Jan 18, 2018	SELL	$147.99 - $163.95 $64,079 - $70,990	-433 Reduced 6.93%	5,815 $928,000
Q3 2017 Oct 23, 2017	BUY	$149.47 - $160.56 $933,888 - $1 Million	6,248	6,248 $943,000

1.94M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $20.6B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Valicenti Advisory Services Inc, based on Form 13F filings with the SEC.

Stay updated on Valicenti Advisory Services Inc with notifications on news.